| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:50 UTC |
|---|
| Update Date | 2022-03-07 02:51:41 UTC |
|---|
| HMDB ID | HMDB0014646 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Ritonavir |
|---|
| Description | Ritonavir, also known as norvir or abbott 84538, belongs to the class of organic compounds known as n-carbamoyl-alpha amino acids and derivatives. N-carbamoyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an carbamoyl group at its terminal nitrogen atom. Ritonavir is a moderately basic compound (based on its pKa). A CYP3A inhibitor and antiretroviral drug from the protease inhibitor class used to treat HIV infection and AIDS, it is often used as a fixed-dose combination with another protease inhibitor, lopinavir. Also used in combination with dasabuvir sodium hydrate, ombitasvir and paritaprevir (under the trade name Viekira Pak) for treatment of chronic hepatitis C virus genotype 1 infection as well as cirrhosis of the liver. An L-valine derivative that is L-valinamide in which alpha-amino group has been acylated by a methylcarbamoyl group and in which a hydrogen of the carboxamide amino group has been replaced by a (2R,4S,5S)-4-hydroxy-1,6-diphenyl-5-{amino}hexan-2-yl group. |
|---|
| Structure | CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1 InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| Norvir | Kegg | | Abbott 84538 | HMDB | | 538, ABT | HMDB | | ABT-538 | HMDB | | ABT 538 | HMDB |
|
|---|
| Chemical Formula | C37H48N6O5S2 |
|---|
| Average Molecular Weight | 720.944 |
|---|
| Monoisotopic Molecular Weight | 720.312760056 |
|---|
| IUPAC Name | 1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate |
|---|
| Traditional Name | ritonavir |
|---|
| CAS Registry Number | 155213-67-5 |
|---|
| SMILES | CC(C)[C@H](NC(=O)N(C)CC1=CSC(=N1)C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)CC1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1 |
|---|
| InChI Key | NCDNCNXCDXHOMX-XGKFQTDJSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as n-carbamoyl-alpha amino acids and derivatives. N-carbamoyl-alpha amino acids and derivatives are compounds containing an alpha amino acid (or a derivative thereof) which bears an carbamoyl group at its terminal nitrogen atom. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | N-carbamoyl-alpha amino acids and derivatives |
|---|
| Alternative Parents | |
|---|
| Substituents | - Valine or derivatives
- N-carbamoyl-alpha-amino acid or derivatives
- Alpha-amino acid amide
- Amphetamine or derivatives
- 2,4-disubstituted 1,3-thiazole
- Monocyclic benzene moiety
- Fatty amide
- Fatty acyl
- N-acyl-amine
- Benzenoid
- Azole
- Heteroaromatic compound
- Carbamic acid ester
- Thiazole
- Carboxamide group
- Urea
- Carbonic acid derivative
- Secondary alcohol
- Secondary carboxylic acid amide
- Organoheterocyclic compound
- Azacycle
- Alcohol
- Organic nitrogen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Organonitrogen compound
- Organooxygen compound
- Organopnictogen compound
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.0013 g/L | Not Available | | LogP | 3.9 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.29 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 17.5548 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.31 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 63.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3440.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 171.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 250.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 153.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 159.5 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 610.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 717.3 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 111.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1565.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 742.1 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2111.5 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 409.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 411.8 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 94.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 106.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 9.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Ritonavir,2TMS,isomer #1 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)[Si](C)(C)C)=CS1 | 5214.2 | Semi standard non polar | 33892256 | | Ritonavir,2TMS,isomer #1 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)[Si](C)(C)C)=CS1 | 4234.1 | Standard non polar | 33892256 | | Ritonavir,2TMS,isomer #1 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)[Si](C)(C)C)=CS1 | 6830.0 | Standard polar | 33892256 | | Ritonavir,2TMS,isomer #2 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)=CS1 | 5335.9 | Semi standard non polar | 33892256 | | Ritonavir,2TMS,isomer #2 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)=CS1 | 4337.8 | Standard non polar | 33892256 | | Ritonavir,2TMS,isomer #2 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)=CS1 | 6955.5 | Standard polar | 33892256 | | Ritonavir,2TMS,isomer #3 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)=CS1 | 5315.1 | Semi standard non polar | 33892256 | | Ritonavir,2TMS,isomer #3 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)=CS1 | 4324.9 | Standard non polar | 33892256 | | Ritonavir,2TMS,isomer #3 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O[Si](C)(C)C)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)=CS1 | 6936.2 | Standard polar | 33892256 | | Ritonavir,2TMS,isomer #4 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)[Si](C)(C)C)=CS1 | 5166.2 | Semi standard non polar | 33892256 | | Ritonavir,2TMS,isomer #4 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)[Si](C)(C)C)=CS1 | 4377.7 | Standard non polar | 33892256 | | Ritonavir,2TMS,isomer #4 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)[Si](C)(C)C)=CS1 | 6966.6 | Standard polar | 33892256 | | Ritonavir,2TMS,isomer #5 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)[Si](C)(C)C)=CS1 | 5106.8 | Semi standard non polar | 33892256 | | Ritonavir,2TMS,isomer #5 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)[Si](C)(C)C)=CS1 | 4362.3 | Standard non polar | 33892256 | | Ritonavir,2TMS,isomer #5 | CC(C)C1=NC(CN(C)C(=O)N([C@H](C(=O)N[C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)C(C)C)[Si](C)(C)C)=CS1 | 6927.1 | Standard polar | 33892256 | | Ritonavir,2TMS,isomer #6 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)[Si](C)(C)C)C(C)C)=CS1 | 5237.1 | Semi standard non polar | 33892256 | | Ritonavir,2TMS,isomer #6 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)[Si](C)(C)C)C(C)C)=CS1 | 4451.6 | Standard non polar | 33892256 | | Ritonavir,2TMS,isomer #6 | CC(C)C1=NC(CN(C)C(=O)N[C@H](C(=O)N([C@@H](CC2=CC=CC=C2)C[C@H](O)[C@H](CC2=CC=CC=C2)N(C(=O)OCC2=CN=CS2)[Si](C)(C)C)[Si](C)(C)C)C(C)C)=CS1 | 7046.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (Non-derivatized) - 70eV, Positive | splash10-00mp-8670529100-3954882109d6e535e591 | 2017-11-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Ritonavir GC-MS (TBDMS_1_4) - 70eV, Positive | Not Available | 2021-10-18 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir LC-ESI-qTof , Positive-QTOF | splash10-0006-0000040900-e9dc614463601a1c3dd2 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 50V, Positive-QTOF | splash10-0002-0920000000-fb7e9eec3c4517a4ccfd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 35V, Negative-QTOF | splash10-0r0r-0000209000-f8dc66aebfcb8d1ee782 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 50V, Positive-QTOF | splash10-0005-0920000000-c12cee7c411b89070236 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 10V, Positive-QTOF | splash10-00di-0010000900-3ae7e7ad9d57c22d3932 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 30V, Positive-QTOF | splash10-00kb-0290000000-6a3201b00601db4afaa0 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 20V, Positive-QTOF | splash10-0002-0090100100-4cc1c98991c6a5a6480b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 10V, Positive-QTOF | splash10-00di-0010000900-452a2165cb00b246b72f | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 20V, Positive-QTOF | splash10-0002-0090100100-c780572b42bde0af761c | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 35V, Positive-QTOF | splash10-00r2-0890300200-f59b087405b85f1cbc70 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 40V, Positive-QTOF | splash10-014j-0690000000-5e0ee9913c1179bd89cb | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 40V, Positive-QTOF | splash10-014j-0790000000-e670b81ff961dafdfef1 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 30V, Positive-QTOF | splash10-00kb-0190000000-1d9d5de9325419431bdd | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ritonavir 40V, Positive-QTOF | splash10-014j-0690000000-087c73e8813347d6d309 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 10V, Positive-QTOF | splash10-0fk9-0920411700-c3a50f415656af90e59a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 20V, Positive-QTOF | splash10-00dl-0920200000-79927271b2c0e85fc1c3 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 40V, Positive-QTOF | splash10-0006-3920000000-99a4f5a7ce28f04a2716 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 10V, Negative-QTOF | splash10-0uxr-3910025300-6c62c0d75b7173f91646 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 20V, Negative-QTOF | splash10-0udi-5932147200-a639a1bd59a42a445759 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 40V, Negative-QTOF | splash10-000i-9000000000-4825afefb6430d347a1a | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 10V, Negative-QTOF | splash10-02t9-1453012900-64ecb833a96b77ff28e5 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 20V, Negative-QTOF | splash10-000f-9205513200-af07698041b04b491aa1 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 40V, Negative-QTOF | splash10-06uu-4900002000-6dededfdad35042e5002 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 10V, Positive-QTOF | splash10-00xr-0790100200-ff28547a81851ed15269 | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ritonavir 20V, Positive-QTOF | splash10-006x-1910000000-7d5614dc0ce74add538a | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|